Clinical trial
A Study to Evaluate the Feasibility and Safety of Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With Functional Mitral Regurgitation
NCT07188233 is registered in ClinicalTrials.gov with HVR Cardio Oy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Feasibility and Safety of Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With Functional Mitral Regurgitation
- Lead sponsor
- HVR Cardio Oy
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 16, 2024
- Completion date
- July 31, 2026
- Enrollment
- 5 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve regurgitation (degenerative or functional)